NEW RIVER PHARMACEUTICALS INC 4
4 · NEW RIVER PHARMACEUTICALS INC · Filed Jan 31, 2007
Insider Transaction Report
Form 4
KIRK RANDAL J
DirectorChairman, President and CEO10% Owner
Transactions
- Award
Stock Appreciation Right
2007-01-25+298,200→ 298,200 totalExercise: $56.39Exp: 2017-01-24→ Common Stock (298,200 underlying)
Footnotes (2)
- [F1]All of these SARs are payable in cash.
- [F2]Vests in three equal annual installments beginning on January 25, 2008, but at all times the exercise of such SARs will be subject to the satisfaction by the Issuer of a liquidity formula as a condition to exercise of the SARs. The vesting of these SARs will accelerate in the event of a change in control of the Issuer.